ASHKA EVERETTE: Open Payments
NPI 1104698992 · NORFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,519 in 29 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $841 · 2025 $1,519
Food & beverage: $1,519
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $262 |
| Ardelyx, Inc. | 7 | $213 |
| AKEBIA THERAPEUTICS INC | 2 | $144 |
| NxStage Medical, Inc. | 1 | $141 |
| Amgen Inc. | 2 | $129 |
| Outset Medical Inc | 1 | $125 |
| CorMedix Inc. | 1 | $120 |
| Bard Peripheral Vascular, Inc. | 1 | $117 |
| Travere Therapeutics, Inc. | 3 | $82 |
| AstraZeneca Pharmaceuticals LP | 3 | $66 |
Products named: Vafseo, NXSTAGE SYSTEM ONE, XPHOZAH 30 MG, JYNARQUE, TAVNEOS, DEFENCATH, IBSRELA, FARXIGA.
Industry payments across VA — which companies pay providers there.
